Gynecologic Oncology | Joyce Liu, MD, MPH

Beyond the Guidelines: Perspectives on the Role of PARP Inhibition in the Management of Ovarian Cancer — Faculty Presentation 1: Genetic Testing in Ovarian Cancer (OC) and Biologic Basis for the Use of PARP inhibitors — Dr Liu CME information and select publications